Cellular stress leads to activation of erythrocyte cation channels with subsequent Ca 2+ entry and stimulates a sphingomyelinase with subsequent formation of ceramide. Both signaling molecules then activate the death program of erythrocytes (eryptosis) which is characterized by phosphatidylserine exposure, cellular shrinkage, membrane blebbing and activation of death-inducing proteases. Some of the mediators accounting for activation of the erythrocyte death machinery, i. e. prostaglandin E 2 (PGE 2 ) and platelet activating factor (PAF), have been described and the respective signaling cascades disclosed. The present article outlines and discusses the methods which have been used to analyze erythrocyte death pathways. Furthermore, some of the pathophysiological implications of eryptosis signaling are delineated and the methods to screen for eryptosis defects in those conditions are presented. Needless to say that further research will be required to fully understand the mechanisms leading to suicidal red blood cell death and to elucidate the role of eryptosis during anemic complications.
Introduction
Cell injury of erythrocytes, such as osmotic shock, glucose depletion and oxidative stress, activates an amiloride-sensitive, Ca 2+ -permeable cation channel K.S. Lang et al. 2003a ). The subsequent elevation of intracellular Ca 2+ activity triggers membrane blebbing, cellular shrinkage, activation of the Ca 2+ -dependent protease l-calpain and scrambling of the cell membrane with breakdown of phosphatidylserine asymmetry (Berg et al. 2001; Bratosin et al. 2001 ; K.S. P.A. Lang et al. 2005b) . Since the sequence of events resembles apoptosis of nucleated cells (Green and Reed 1998; Gulbins et al. 2000) , the term eryptosis was introduced to describe this particular kind of cell death (K.S. Lang et al. 2005) . In contrast to nucleated cells Prokop et al. 2000; Wieder et al. 2001a, b; von Haefen et al. 2003) , however, erythrocyte programmed cell death after most triggers of cell injury does not require caspase activation (Weil et al. 1998; Berg et al. 2001 ; K.S. Lang et al. 2004a) , even though caspases are expressed in erythrocytes and activated by oxidative stress (Mandal et al. 2003 (Mandal et al. , 2002 . Thus, erythrocytes could be utilized as a 'stripped down' cellular system to investigate caspase-independent suicide mechanisms.
Ca
2+ entry into erythrocytes is mainly regulated by three distinct mechanisms: (i) by protein kinase C-dependent pathways leading to activation of Ca 2+ fluxes across the membrane (Andrews and Low 1999; Yang et al. 2000) , (ii) by phospholipase A 2 -mediated PGE 2 signaling leading to activation of the erythrocyte cation channels (Kaestner et al. 2004; P.A. Lang et al. 2005b ) and (iii) by erythropoietin-mediated inhibition of the cation channels (Myssina et al. 2003) .
In addition to the Ca 2+ -dependent signaling cascades, eryptosis is regulated by ceramide (K.S. Lang et al. 2004a ), shown to be involved in apoptosis of several cell types (Frago et al. 1998; Goldkorn et al. 1998; Raisova et al. 2000; von Haefen et al. 2002; Kolesnick and Fuks 2003; Ogretmen and Hannun 2004) . Ceramide is generated from membrane phospholipids by a shrinkage-dependent sphingomyelinase and sensitizes the erythrocytes for cytosolic Ca 2+ thereby triggering scrambling of the cell membrane even in the absence of Ca 2+ entry (K.S. Lang et al. 2004a ). Further detailed investigations revealed that erythrocyte ceramide formation and cell membrane scrambling is governed by platelet activating factor (PAF) via a PAF receptor-dependent mechanism (P.A. Lang et al. 2005c) . Along those lines, PAF, a phospholipid mediator involved in the regulation of inflammation, thrombosis, atherogenesis and cardiovascular function (Bussolino et al. 1989; Montrucchio et al. 1993 Montrucchio et al. , 2000 Subbanagounder et al. 1999; Haynes and Obiako 2002; Zimmerman et al. 2002; Goggel et al. 2004 ) is released from erythrocyte progenitor cells upon increase of cytosolic Ca 2+ activity (Dupuis et al. 1997) . PAF further activates Ca 2+ -sensitive K + channels (Gardos channels) in the erythrocyte cell membrane (Garay and Braquet 1986 ) by sensitising them for the stimulating effects of cytosolic Ca 2+ (Rivera et al. 2002) . Thus, PAF is involved in the regulation of two hallmarks of eryptosis, namely K + -mediated shrinkage and ceramidemediated phospholipid scrambling.
The scrambling of the cell membrane following increase of cytosolic Ca 2+ -activity (Woon et al. 1999) or ceramide formation (K.S. Lang et al. 2004a) leads to phosphatidylserine exposure at the erythrocyte surface which may either facilitate cell-cell interactions and the formation of cell aggregates (Eda and Sherman 2002; K.S. Lang et al. 2004b) or lead to accelerated clearance of damaged erythrocytes by macrophages which are equipped with receptors specific for phosphatidylserine (Fadok et al. 2000) .
Erythrocytes can be easily obtained at high purity and in large amounts by standard purification procedures. In contrast to previous assumptions, erythrocytes still contain the molecular machinery to regulate different intracellular signaling pathways on a posttranslational level, e.g. phospholipase-mediated, receptor-triggered and kinase-dependent pathways (Barvitenko et al. 2005 ; K.S. Lang et al. 2005) . Here, we present and discuss the experimental procedures that shed light on the suicide machinery of this organelle-free cell type. Due to their good reproducibility and high throughput, we focus on flow cytometric measurements to screen for effects of different stressors on erythrocyte membrane asymmetry (annexin binding assay), cell volume (forward scatter), Ca 2+ concentration (Fluo-3-dependent fluorescence) and cellular ceramide levels (antibody-based determination). The methods are complemented by more sophisticated biochemical analyses, e. g. enzymatic determination of ceramide, breakdown of metabolically labeled sphingomyelin, Western blotting, and patch clamp techniques for electrophysiological analysis. 
Materials

Procedures
Blood cells, purification of erythrocytes and determination of blood cell numbers For erythrocyte signaling experiments, highly purified erythrocyte concentrates should be used. Human whole blood is drawn from healthy volunteers and erythrocyte concentrates are obtained by filtration (P.A. Lang et al. 2005c ). In any case, the purity of the erythrocyte concentrates has to be measured by different automated procedures as outlined below.
Human whole blood is drawn from healthy volunteers and erythrocyte concentrates are obtained using the OptiPure RC quadruple blood pack set equipped with a soft housing red cell filter. About 500 ml of whole blood are automatically mixed with 70 ml CPD buffer containing 3.27 mg/ml citric acid, 26.30 mg/ml sodium citrate, 2.50 mg/ml sodium dihydrogenphosphate dihydrate and 25.50 mg/ml dextrose monohydrate. Blood components are separated by centrifugation at 4795 g for 10 min at 22°C. Plasma, buffy coat and erythrocytes are then pressed into the respective blood bags. During this process SAG-M stabilizer solution containing 8.77 mg/ml NaCl, 9.00 mg/ml dextrose monohydrate, 0.17 mg/ml adenine and 5.25 mg/ml mannitol is added to the erythrocytes and the erythrocytes are passed through the integrated leukocyte depletion filter at room temperature. Aliquots of the erythrocyte concentrates are stored at 4°C until usage.
Alternatively (e.g. for Western blot analyses or in animal experiments), erythrocytes are purified by centrifugation of whole blood for 25 min, 2000 g over Percoll, washed 3 times in phosphate buffered saline (PBS) and centrifuged at 450 g for 5 min. Purified erythrocytes should be immediately used for experimental purposes.
Platelet numbers in whole blood and in erythrocyte concentrates as well as leukocytes in whole blood are measured using an automated blood cell counter (CellDyn3000). The cells are identified by a combination of their optical and electrical properties in the appropriate counter medium. Representative erythrocyte concentrates should not contain more than 3% of the original platelet number of the respective whole blood samples. Furthermore, platelet numbers in whole blood and in erythrocyte concentrates are determined by flow cytometric analysis of thiazole orangestained cells using the Retic-COUNT (Thiazole orange) reagent according to the manufacturer's instructions. Measurements are performed on a FACS-Calibur and the number of cells in the thrombocyte gate of the respective forward scatter (FSC) versus thiazole orange-fluorescence intensity (FL-1H) dot plots is determined using the CellQuest TM software. Leukocyte numbers in erythrocyte concentrates are quantified by flow cytometric analysis on a Coulter Epics XL using the internally normalized TrueCount kit. The kit is based on the detection of nucleated cells by the fluorescent DNA-intercalator propidium iodide. Erythrocyte concentrates should contain less than 0.1% of the original leukocyte number of the respective whole blood samples.
Erythrocytes, platelets and leukocytes of whole blood and erythrocyte concentrates are further quantified by the use of a MDM 905 electronic hematology particle counter.
For determination of relative reticulocyte numbers, 5 ll of whole blood are added to 1 ml Retic-COUNT (Thiazole orange) reagent. Samples are stained for 30 min at room temperature in the dark. Then, FACS analysis of stained samples is performed according to the manufacturer's instructions. Forward scatter (FSC), side scatter (SSC) and thiazole orange-fluorescence intensity (in the fluorescence channel FL- P.A. Lang et al. 2003b ) and may serve as a model system for human eryptosis. Thus, the use of specific genetic knockout models (e.g. PAF receptor knockout (PAF-R À/À) mice and the corresponding PAF receptor wild type (PAF-R +/ + littermates) enables us to specifically target distinct parts of the death signaling pathway (P.A. Lang et al. 2005c ). Furthermore, animals (mice or rats) can be fed special diets to investigate the influence of different dietary deficiencies . Animal experiments have to be performed according to international and local regulations and need to be approved by the local authorities. Murine erythrocytes are drawn by retroorbital venopuncture and used after purification over Percoll.
Solutions
In vitro experiments are performed at 37°C in standard Ringer solution in the presence or absence of specific effector molecules, such as PAF (P.A. Lang et al. 2005c ), PGE 2 (P.A. Lang et al. 2005b) , erythropoietin (Myssina et al. 2003) phorbolester (Andrews et al. 2002) etc. In addition, erythrocytes are stressed by increasing or decreasing osmolarity of the standard Ringer solution (K.S. , by removal of glucose from the standard Ringer solution (K.S. or by replacing Cl À ions by gluconate (P.A. Lang et al. 2005b) . Eryptosis can also be induced by treatment of erythrocytes with low concentrations of heavy metals, i.e. lead (Kempe et al. 2005) or mercury ions (Eisele et al. 2005) . To investigate the role of eryptosis in the development of anemic conditions, erythrocytes from patients suffering from genetic disorders, e.g. sickle cell anemia, thalassemia or glucose-6-phosphate dehydrogenase deficiency (K.S. Lang et al. 2002) , are tested in vitro in the experimental set ups described above and compared with erythrocytes from healthy volunteers.
The Ringer solution contains (in mM): 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)/NaOH, 5 glucose, 1 CaCl 2 ; pH 7.4. In some experiments, osmolarity is increased to 850 mOsm by adding sucrose. Osmolarity is measured by the use of a VAPRO 5520 vapor pressure osmometer. Furthermore, glucose is removed from the standard Ringer solution to achieve energy depletion. The effect of glucose removal is enhanced by supplementing glucose-free Ringer solution with 5 mM 2-deoxyglucose which efficiently blocks glycolytic ATP synthesis. Cl À -free Ringer solutions are composed of (in mM): 125 Na-D-gluconate, 5 K-D-gluconate, 1 MgSO 4 , 32 HEPES/ NaOH, 5 glucose, 1 Ca-gluconate 2 ; pH 7.4.
The Ca 2+ ionophore ionomycin (1 lM), the cation channel inhibitor EIPA (10 lM), phospholipase A 2 inhibitors quinacrine (25 lM), palmitoyltrifluoromethyl ketone (PACOCF3; 1-4 lM) or arachidonyltrifluoromethyl ketone (AACOCF3; 8 lM), cyclooxygenase inhibitors acetylsalicylic acid (50 lM) or diclophenac (10 lM), prostaglandin PGE 2 (0.1 nM-50 lM),
, arachidonic acid (1 lM) and thromboxane B 2 (5-50 lM) could be added to modify eryptosis. The substances are dissolved in final concentrations of 0.1% dimethyl sulfoxide (DMSO) (ionomycin, EIPA, quinacrine, acetylsalicylic acid, diclophenac, PACOCF3, AA-COCF3, PAF16, PAF18) or of 0.5% ethanol (PGE 2 , thromboxane B 2 , calpain inhibitors I and II). For appropriate controls, it is mandatory to incubate erythrocytes from the same donor in Ringer solution containing the same concentration of solvent.
Determination of phosphatidylserine exposure, cell volume, cellular ceramide levels and intracellular Ca 2+ concentration by flow cytometry
Fluorescence activated cell sorting (FACS) analysis (Andree et al. 1990 ) is performed with some modifications to adapt the method to erythrocyte research (K.S. Lang et al. 2002 . Erythrocyte concentrates (diluted to 0.3% hematocrit) are treated with different agonists or antagonists. For determination of phosphatidylserine exposure, the cells are washed in annexin-binding buffer containing (in mM): 125 NaCl, 10 HEPES; pH 7.4 and 5 CaCl 2 . Erythrocytes are stained with AnnexinV-Fluos at a 1:100 dilution. After 15 min, samples are diluted 1:5, thoroughly mixed on a vortex mixer to achieve single cell suspensions, and measured by flow cytometric analysis on a FACSCalibur (see Figure 1a) . AnnexinV-fluorescence intensity is measured in the fluorescence channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
To determine the cell volume of stressed erythrocytes, the forward scatter of unstained cells is measured and analyzed on a FACS-Calibur (see Figure 1b ) (K.S. . In case that the cells have been incubated in standard Ringer solution in the presence or absence of different effector molecules, forward scatter analysis can also be accomplished with Annexin V-labelled erythrocytes.
For determination of ceramide, a monoclonal antibody-based assay is used which has been validated earlier (Grassme et al. 2002; Bieberich et al. 2003) . After incubation, cells are stained for 1 hour at 4°C with 1 lg/ml anti-ceramide antibody or 1 lg/ml isotype-matched pure mouse IgM antibody in PBS containing 1% fetal calf serum (FCS) at a dilution of 1:5 (K.S. Lang et al. 2004a) . After three washes with PBS/1% FCS, cells are stained with polyclonal fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG + IgM specific antibody in PBS/1% FCS at a dilution of 1:50 for 30 min. Unbound secondary antibody is removed by repeated washing with PBS/1% FCS. The samples are analyzed by flow cytometric analysis on a FACS-Calibur. Mean values of FITC-fluorescence intensity in the fluorescence channel FL-1 are determined using the CellQuest TM software. Isotype matched pure mouse antibody should not display increased fluorescence intensity in FL-1 and 1 U/ml purified sphingomyelinase from Streptomyces sp. for 5 min should be used as a positive control.
Intracellular Ca 2+ measurements are performed using the Ca 2+ -dependent fluorescence dye Fluo-3/AM (Andrews et al. 2002) . For this, 10 ml erythrocyte suspension (0.16% hematocrit) are loaded with Fluo-3/AM by addition of 10 ll of a Fluo-3/AM stock solution (2.0 mM in DMSO). After incubation at 37°C for 15 min under vigorous shaking and protection from light, an additional 10 ll of Fluo-3/AM is added, with incubation carried out for 25 min. Fluo-3/AMloaded erythrocytes are centrifuged at 1000 g for 3 min at 22°C and washed twice with Ringer solution containing 0.5% bovine serum albumin (BSA) and once with Ringer. Fluo-3/AM-loaded erythrocytes (0.32% hematocrit) are treated with the respective agonist or with 1 lM ionomycin as a positive control to increase intracellular Ca 2+ activity. After incubation, cells are analyzed by flow cytometric analysis on a FACS-Calibur and Ca 2+ -dependent fluorescence intensity is measured in the fluorescence channel FL-1 (see Figure 1c) .
Human red blood cell (RBC) membrane preparation and Western blotting
Expression of different receptors, protein kinases or proteases is determined by Western blot analysis (Wieder et al. 2001a ). Before analysis, erythrocyte preparations should be checked for platelet and white blood cell contaminations, for example by the use of an electronic hematology particle counter (MDM 905). Purified erythrocyte preparations should contain less than 3-5% contaminating cells as compared with the platelet counts and white blood cell counts of the respective, original whole blood samples. To remove the hemoglobin, 200 ll of the erythrocyte pellet are hemolyzed in 50 ml of 20 mM HEPES/NaOH (pH 7.4) containing a cocktail of protease inhibitors composed of 2.5 mM ethylenediamine tetraacetic acid (EDTA), 10 lg/ml pepstatin A, 10 lg/ml leupeptin, 5 lg/ml aprotinin and 0.1 mM phenylmethylsulfonyl fluoride (PMSF). Ghost membranes are pelleted (15,000 rpm for 20 min at 4°C) and solubilized in 125 mM NaCl, 25 mM HEPES/NaOH (pH 7.3), 10 mM EDTA, 10 mM Na-pyrophosphate, 10 mM NaF, 0.1% sodium dodecyl sulphate (SDS), 0.5% deoxycholic acid, 1% Triton-X-100, and 10 ll b-mercaptoethanol. The protein concentration of the samples is determined with the Bradford method with BSA as standard. Lysates are separated by 10% SDS-PAGE (50 lg protein per lane), and transferred to Protan BA83 nitrocellulose membranes. Protein transfer is controlled by Ponceau red staining. After blocking with 5% nonfat-dried milk at room temperature for 1 h, the blots are probed overnight at 4°C with a specific primary antibody against the protein in question (e.g. polyclonal goat anti-PAF receptor antibody directed against the N-terminus of the human PAF receptor (PAF-R (N-17)) at 1:200 dilution. The blots are incubated overnight in the presence or absence of 10 lg/ml specific blocking peptides. After washing, the blots are incubated with a secondary peroxidase-conjugated antibody, e.g. a donkey anti-goat antibody (at 1:2000 dilution) for 1 h at room temperature. Antibody binding is detected with the enhanced chemiluminescence ECL kit. To test for contamination of the erythrocyte membrane preparations by platelets, Western blot analysis is performed in parallel using a monoclonal mouse anti-human CD61 antibody at 1:200 dilution combined with a sheep anti-mouse antibody conjugated with horseradish peroxidase at 1:1000 dilution.
Determination of phospholipase A 2 (PLA 2 )-derived signaling molecules after cellular stress Membrane as well as cytosolic PLA 2 isoenzymes are expressed in mature erythrocytes (MacDonald Samples are stirred on a vortex mixer and centrifuged at 13,000 g for 2 min. Phase separation is accomplished by the addition of 125 ll chloroform and 125 ll water. The suspension and centrifugation steps are repeated, and 100 ll of the chloroform phases are transferred to scintillation vials and dried under nitrogen. Then, PAF is determined using the PAF [ 3 H] Scintillation Proximity Assay (SPA) system according to the manufacturer's instructions. [ 3 H]PAF bound to the fluomicrospheres is counted in a ß-scintillation counter and the concentration of PAF in the samples is calculated from a PAF calibration curve (20-1280 pg/tube) which has been run in parallel.
For determinatiom of PGE 2 release following osmotic shock, erythrocytes are incubated in hypertonic Ringer solution (850 mOsm) or in the presence of other stressors and subsequently pelleted. PGE 2 is determined in the supernatant. In detail, one billion erythrocytes are treated with 0.9 ml hypertonic NaCl Ringer solution (850 mOsm) in the absence or presence of Ca
2+
(1 mM), with hypertonic NaCl Ringer solution (850 mOsm) in the absence or presence of 25 lM PLA 2 inhibitor quinacrine, with isotonic Na-gluconate solution (0 mM Cl À ), with ionomycin (1 lM) or with isotonic NaCl Ringer solution (300 mOsm) as control. After incubation, cells are pelleted by centrifugation at 4°C, 450 g for 5 min. The supernatant is removed and stored at À20°C until usage. PGE 2 concentrations in the supernatant are then determined using the Correlate-EIA TM Prostaglandin E 2 Enzyme Immunoassay Kit according to the manufacturer's instructions. The samples are diluted 1:2.5 with assay buffer. Then, 100 ll sample, 50 ll alkaline phosphatase PGE 2 conjugate and 50 ll monoclonal anti-PGE 2 EIA antibody are applied to goat anti-mouse IgG microtiter plates and incubated at room temperature for 2 h. After washing, 200 ll p-nitrophenyl phosphate substrate solution is added and incubated at room temperature for 45 min. Finally, the optical density at 405 nm is measured in a microplate reader. PGE 2 concentrations in the samples are calculated from a PGE 2 standard curve (39.1-5000 pg/ml) which is run in parallel. PGE 2 levels in the supernatants of control (Ringer-treated) erythrocytes should be in the range of 100 pg per 10 9 cells and are set as 100%. PGE 2 levels in the samples of erythrocytes exposed to hyperosmotic Ringer, Cl À -free extracellular fluid or ionomycin are calculated as % of the appropriate controls.
Biochemical determination of cellular ceramide using diacylglycerol (DAG)-kinase
In some cases (e.g. in mouse erythrocytes or when human erythrocytes are stimulated with antibodies), it is not possible to determine ceramide levels by the antibody-based flow cytometric method. Furthermore, absolute ceramide levels cannot be measured by this technique. We therefore established a biochemical method to confirm the data from FACS analysis. After stimulation of erythrocytes, the samples are extracted in chloroform:methanol:1N HCl (100:100:1), the lower phase is collected and dried. Diacylglycerol is then degraded by alkaline hydrolysis of the samples in 100 ll of 0.1 N methanolic KOH at 37°C for 60 min. The samples are re-extracted, dried and resuspended in 20 ll of detergent solution (7.5% (w/v) n-octylglucopyranoside, 5 mM cardiolipin in 1 mM diethylenetriaminepentaacetic acid (DETAPAC)). The samples are then sonicated for 10 min in a bath sonicator and the kinase reaction is initiated by addition of 70 ll reaction mix consisting of 10 ll DAG-kinase (in 5 mM potassium phosphate buffer (pH 7.0), 10% glycerol, 1 mM 2-mercaptoethanol, 0.005 M imidazole/HCl, 0.5 mM DETAPAC (pH 6.6)), 50 ll assay buffer (0.1 M imidazole/HCl (pH 6.6), 0.1 M NaCl, 25 mM MgCl 2 and 2 mM EGTA), 2.8 mM dithiothreitol (DTT), 5 lM ATP and 10 lCi [ 32 P]cATP. The kinase reaction is performed for 30 min at room temperature. The reaction is terminated by addition of 1 ml of chloroform: methanol: 1 N HCl (100:100:1). About 170 ll of a buffered saline solution (135 mM NaCl, 1.5 mM CaCl 2 , 0.5 mM MgCl 2 , 5.6 mM glucose, 10 mM HEPES pH 7.2) and 30 ll of a 100 mM EDTAsolution are added. The samples are extracted, the lower phases collected, dried, dissolved in 20 ll of chloroform: methanol (1:1) and separated on Silica G60 thin layer chromatography plates with chloroform: methanol: acetic acid (65:15:5). The plate is exposed, ceramide identified by co-migration with an identical standard, scraped from the plate and quantified by liquid scintillation counting. The amount of ceramide is determined by comparison with a ceramide standard curve using C 16 -ceramide.
Determination of the sphingomyelin cycle
To determine the origin of elevated ceramide levels, erythrocytes are metabolically labelled using [methylÀ 3 H]choline chloride (K.S. Lang et al. 2004a) . After labelling, the cells are washed and lipids are extracted. Then, sphingomyelin is quantified using bacterial sphingomyelinase to release [ 3 H]phosphocholine (Jayadev et al. 1994 ). In detail, cells are labelled by incubation of erythrocyte concentrates (10% hematocrit) for 72 h in the presence of 7.4 · 10 4 Bq/ml [methylÀ 3 H]choline chloride. After labelling, cells are washed twice with Ringer and reseeded at 2 · 10 8 cells/ml in control Ringer solution or in Ringer solution containing different cellular stressors. After incubation, cells are washed twice using 1 ml of Ringer solution. Lipids are extracted by the modified method of Bligh and Dyer as described above. About 20 ll of the chloroform phases are taken for scintillation counting, and 50 ll of the chloroform phases are dried under nitrogen and used for sphingomyelin measurements. To this end, cellular lipids are resuspended in 100ll assay buffer (100 mM Tris-HCl, pH 7.4, 6 mM MgCl 2 , 0.1% Triton X-100). Samples are sonicated and 1 U/ml sphingomyelinase from streptomyces sp. is added. Reaction mixtures are incubated for 2 h at 37°C. Reactions are stopped by addition of 1.0 ml chloroform/methanol (2:1, v/v). Phase separation is completed by addition of 100 ll water. Sphingomyelin is quantified by counting the upper, aqueous phase, containing the liberated [ 3 H]phosphocholine, and phosphatidylcholine is quantified by drying and counting the lower, organic phase in a ß-scintillation counter. Where appropriate, sphingomyelin is normalized using phosphatidylcholine measurements. Blank reactions contain no sphingomyelinase. The radioactivity of control samples normally reaches approx. 1800 dpm/10 9 cells and is set as 100%. Subsequently, the sphingomyelin concentration in the samples of stressed cells is calculated as % of control. Optimization studies have illustrated that the above conditions yielded maximal sphingomyelin hydrolysis (100%).
Patch clamp
To study the functional significance of cation channels during eryptosis, the patch clamp technique has been adapted to mature red blood cells (Huber et al. 2001) . Patch clamp experiments are performed in voltage-clamp, fast whole-cell mode according to Hamill et al. (Hamill et al. 1981) as outlined in detail below. In human and mouse erythrocytes, several (e.g. K + -, nonselective cation-, and Cl À -selective) whole-cell conductances have been defined and their role for eryptosis has been characterized (for review see Huber et al. 2005) .
The erythrocytes are sedimented on a plastic cell culture dish mounted on an inverted microscope. The cells are continuously superfused with NaCl Ringer solution through a flow system inserted into the dish. The bath is grounded via a bridge filled with NaCl Ringer solution. Borosilicate glass pipettes manufactured by a microprocessor-driven DMZ puller are used in combination with a MS314 electrical micromanipulator. The currents are recorded by an EPC-9 amplifier using Pulse software (Heka) and an ITC-16 Interface. The holding potential is set to À30 mV which induces and stabilizes the seal resistances in the range of 10 gigaohms. Voltage-dependent sealing may take minutes. Seal formation may be improved by bath solutions containing high concentrations (5-10 mM) of Ca 2+ and Mg 2+ (for instance a solution designed by Desai et al. (2000) ). Electrical access to the whole plasma membrane is accomplished by short negative pressure pulses applied to the pipette lumen optionally combined with 500 mV/150 lS voltage pulses. Whole cell recording mode is indicated by a minute increase of the capacitative current transients and simultaneous bleaching of the recorded erythrocyte. Whole cell currents are determined during successive square pulses to voltages between À100 mV and +80 mV (+100 mV).
In erythrocytes, whole-cell recording seal resistances may be highly voltage-dependent. As a consequence, leak currents which exhibit a slight cation-selectivity may become rectifying and timedependent activating/inactivating and, thus, be misinterpreted as biological currents. To distinguish leak currents from currents through nonselective cation channels, inhibitors such as amiloride (Gamper et al. 2000) , GdCl 3 , or ethylisopropylamiloride (K.S. P.A. Lang et al. 2005b ) may be used. In addition, substitution of Na + by the impermeant cation N-methyl-D-glucamine + (NMDG + ) results in an about 50 mV shift of the reversal potential of cation channel-generated currents which is paralleled by a dramatic decrease of inward current (P.A. Lang et al. 2005b ). Leak currents, in contrast, shift only by some 10 mV and exhibit only small current declines upon bath cation substitution.
The nonselective cation whole-cell conductance of erythrocytes is Ca 2+ -permeable, exhibits a permselectivity for monovalent cations of Cs + > K + > Na + = Li + > > NMDG + and is activated by removal of intracellular or extracellular Cl À (Huber et al. 2001; Duranton et al. 2002; Duranton et al. 2003) , oxidative stress , hyperosmotic cell shrinkage (Huber et al. 2001; K.S. Lang et al. 2003a ) and PGE 2 (P.A. Lang et al. 2005b ) (see also Figure 2 ). The nonselective cation currents are inhibited by hypoosmotic cell swelling (Huber et al. 2001) , high intra-and extracellular Cl À concentrations (IC 50 of about 27 mM extracellular Cl À ) (Huber et al. 2001; Duranton et al. 2002) , erythropoietin (Myssina et al. 2003 ) and catecholamines (P.A. Lang et al. 2005a) .
To measure the nonselective cation currents, a Na + -containing pipette solution with reduced Cl À concentration is used in our laboratory (115 mM Na-D-gluconate, 5 mM MgCl 2 5 mM Hepes/NaOH, 1 mM Mg-ATP, 1 mM EGTA; pH 7.4). In combination with NaCl Ringer solution the Cl À equilibrium potential is at high negative voltages, which facilitates the discrimination between cation and Cl À currents. The latter can be elicited in erythrocytes by Plasmodium infection (Desai et al. 2000) , oxidative stress , cell swelling , and protein kinase A (Egee et al. 2002; Verloo et al. 2004) .
To measure Gardos K + channel activity (Egee et al. 2002; P.A. Lang et al. 2003a) erythrocytes are recorded with K-gluconate/KCl pipette solu- Figure 2 . The non selective cation channels of human erythrocytes as analyzed by whole-cell patch-clamp recording. Current traces recorded with KCl/K-gluconate pipette and Standard NaCl Ringer bath solution (as indicated) before (control), during (PGE 2 ), and after (wash-out) bath application of prostaglandin E 2 (PGE 2 ; 100 nM). The currents are evoked by 10 successive square-pulses to voltages between À100 mV and +80 mV (delivered in 20 mV increments). In the depicted traces the currents of the individual square pulses are superimposed and the zero current indicated by the grey line. The inward currents, defined as flow of positive charge from the extracellular to the cytoplasmic membrane face (or the opposite movement of anions), are negative currents and depicted as downward deflections of the current traces. The applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. tion (60 mM K-D-gluconate, 60 mM KCl, 1 mM EGTA, 1 mM MgCl 2 , 1 mM Mg-ATP, and 10 mM HEPES/KOH; pH 7.4) in combination with K + -containing standard NaCl Ringer solution. K + channel activity can be stimulated in Ca 2+ -containing bath solution by the Ca 2+ ionophore ionomycin or by hemolysins (P.A. Lang et al. 2004) , lead (Kempe et al. 2005) or mercury ions (Eisele et al. 2005) . Clotrimazole is well suited to inhibit Gardos channels.
Calcium measurements
Intracellular calcium plays a crucial role in the signaling pathways leading to eryptosis (Bratosin et al. 2001; Daugas et al. 2001; Barvitenko et al. 2005 ; K.S. Lang et al. 2005) . On the other hand, Ca 2+ entry is more rapid in old erythrocytes than in young red blood cells (Romero and Romero 1999) . To study Ca 2+ entry during eryptosis, Ca 2+ flux is measured using the radioactive tracer ion 45 Ca 2+ (Staines et al. 1999; Tiffert and Lew 1997) , with some modifications to adapt the experimental conditions to cellular stress (K.S. Lang et al. , 2004a . is added from a 100 mM CaCl 2 stock solution with a specific activity of about 10 7 c.p.m. per lmol to reach a final concentration of 150 lM. After different time periods, 100 ll aliquots are delivered into 1.2 ml of ice cold solution B with 0.2 mM CoCl 2 and 1 mM amiloride. The cells are collected by centrifugation in an Eppendorf centrifuge (14,000 rpm for 0.5 min, 4°C) and the cell pellet is washed twice using 1 ml of the same medium. The supernatant is discarded, the cells are lysed, and the proteins are precipitated by addition of 0.6 ml 6% trichloroacetic acid. After a further spin (14,000 rpm for 2 min, 4°C), 0.5 ml of the clear supernatants are used for measuring 45 Ca 2+ radioactivity by scintillation counting in a ß-scintillation counter.
45 Ca 2+ specific activity is determined in parallel by addition of 0.6 ml 6% trichloroacetic acid to 100 ll of erythrocyte suspension and centrifugation as described above. Then, 100 ll of the clear supernatants are taken for scintillation counting. 
Statistics
Erythrocytes from different donors show a relatively high degree of variability. Thus, all experiments using the described methods have to be repeated with several blood samples from different individuals (4 to 10 donors). If the researchers follow the instructions described above a good reproducibility of the results can be expected with a SEM below 10% of the mean value (see also Figure 1d ). Data are always expressed as arithmetic means ± SEM and statistical analyses have to be made by paired or unpaired t-test, or ANOVA using Dunnett's or Tukey's test as post hoc test, where appropriate.
Results and discussion
The induction of phosphatidylserine exposure and erythrocyte shrinkage after ionomycin treatment was originally described in vitro with purified erythrocyte preparations from healthy donors. In these reports, purification of erythrocytes was achieved by centrifugation procedures (Berg et al. 2001; Bratosin et al. 2001) and it was shown in a later study that purified and non-purified erythrocytes from the same donor showed similar susceptibility towards cellular stress (K.S. . However, for analysis of eryptosis signaling, particular care should be placed on the purification and analysis of the cell population. In a study dealing with PAF signaling, we thus used highly purified erythrocyte concentrates which had been prepared by filtration over leukocyte depletion filters (P.A. Lang et al. 2005c) .
To demonstrate the significance of eryptosis signaling for anemic diseases, it is necessary to analyze red blood cells from patients suffering from anemia (K.S. Lang et al. 2002) . Since erythrocytes from healthy patients show differences in their susceptibility towards stress-induced eryptosis, it is mandatory to always investigate diseased erythrocytes side by side with normal controls. This approach has already been successfully used in patients suffering from chronic renal failure and receiving erythropoietin therapy (NeoRecormon). In these experiments, we could demonstrate that erythropoietin treatment significantly decreases phosphatidylserine exposure of circulating erythrocytes in vivo (Myssina et al. 2003) .
Genetic manipulation of mature erythrocytes is not possible. Thus, classical genetic approaches to interfere with the human erythrocyte signaling machinery, i.e. antisense technology or RNA interference, can be carried out only in erythrocyte progenitor cells or cell lines with similarities to erythrocytes (e.g. the K-562 cell line). Using the antisense technique, we were able to characterize the role of Ca 2+ -activated K + channels in human erythrocyte 'apoptosis' (P.A. .
Over the last decade, knockout mice have been widely used to study the role of effector proteins in apoptosis (for review see Los et al. (1999) ). In the case of erythrocyte research, the knockout technique represents an elegant method to specifically target eryptosis signaling pathways. Using PAF receptor knockout mice, experimental evidence has been provided that PAF induces erythrocyte phosphatidylserine exposure via a PAF receptordependent mechanism (P.A. Lang et al. 2005c) . In another study, erythrocytes from taurin transporter-deficient mice showed blunted eryptosis sensitivity (P.A. . It should be kept in mind, though, that there may be differences between human and murine erythrocytes. For instance, mouse erythrocytes apparently lack shrinkage-dependent sphingomyelinase activity (unpublished observation).
Flow cytometry is a very convenient and fast method to measure large cell populations. This method has been used to screen for the effects of diverse regulator molecules of apoptosis and to analyze the pathways involved. Thus, different assays using this technique have been applied to erythrocyte suspensions. These assays comprise determination of membrane lipid asymmetry (phosphatidylserine exposure), measurement of cell volume (forward scatter analysis), detection of elevated ceramide levels and determination of intracellular Ca 2+ concentration. Nevertheless, one has to keep in mind that the assays depend on the fluorescence properties of the erythrocytes. Therefore positive as well as negative controls have to be included. In the case of the ceramide assay, treatment of erythrocytes with purified sphingomyelinase may serve as a positive control and the use of an unspecific, isotype matched control antibody as a negative control (Grassme et al. 2002; Bieberich et al. 2003; K.S. Lang et al. 2004a ). The same is true for the flow cytometric determination of intracellular Ca 2+ activity where treatment with ionomycin or other Ca 2+ ionophores should be included as positive control into each series of experiments (Andrews et al. 2002; P.A. Lang et al. 2005b) .
The flow cytometric measurements of cell volume, cellular ceramide levels and intracellular Ca 2+ concentrations should be confirmed by independent (biochemical) methods. In detail, cell volume can be measured conventionally using micro hematocrit tubes in combination with a microhematocrit centrifuge , cellular ceramide can be determined enzymatically by the use of DAG kinase (P.A. Lang et al. 2005c) and Ca 2+ entry can be measured by 45 Ca 2+ uptake assays (K.S. .
The application of novel experimental procedures and tools allowed to redefine some features of erythrocyte physiology. For example, in binding studies using radioactive PAF it was demonstrated that mature erythrocytes do not contain high affinity binding sites for PAF. The authors concluded from those data that erythrocytes do not contain PAF receptors (Hwang et al. 1983 ) although specific antibodies against the human PAF receptor were not available at this time. In a recent study, however, it was shown by Western blot that highly purified erythrocyte concentrates contain significant amounts of PAF receptor and undergo PAF-mediated eryptosis (P.A. Lang et al. 2005c ). Interestingly, these data can serve as an additional explanation for the PAF-mediated adherence of sickle erythrocytes to endothelium (Kaul et al. 2000 (Kaul et al. , 2001 .
Another example for new concepts in erythrocyte biology is the assumption that mature erythrocytes still contain erythropoietin receptors and that erythropoietin is able to influence eryptosis at the level of the nonspecific cation channels. This concept was confirmed by patch clamp measurements in the presence or absence of erythropoietin. Additionally, high affinity erythropoietin binding sites on mature erythrocytes were determined by the use of [
125 I]Iodotyrosyl)erythropoietin (molecular weight: 34,000 D) (Myssina et al. 2003) .
In summary, human and murine erythrocytes represent well characterized cellular systems which will enable future research on cell death signaling pathways which are independent of intracellular organelles, i.e. nuclei or mitochondria.
